BostonGene Corporation – Trademark Portfolio
Entity Type: 03
BostonGene Corporation holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include BOSTONGENE and MF PORTRAIT. The owner is based in Waltham, MA.
95 Sawyer Road
Waltham, MA 02453
Showing of trademarks Trademarks
Trademark Classifications
BostonGene Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BostonGene Corporation have?
BostonGene Corporation has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned.
What trademark classes does BostonGene Corporation file in?
BostonGene Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BostonGene Corporation's most well-known trademarks?
BostonGene Corporation's registered trademark portfolio includes well-known marks such as BOSTONGENE and MF PORTRAIT. These are among 4 currently registered trademarks in the portfolio.
What is BostonGene Corporation's trademark registration success rate?
BostonGene Corporation has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.